MACULAR TELANGIECTASIA TYPE 2 (MACTEL)

Clinical trials for MACULAR TELANGIECTASIA TYPE 2 (MACTEL) explained in plain language.

Never miss a new study

Get alerted when new MACULAR TELANGIECTASIA TYPE 2 (MACTEL) trials appear

Sign up with your email to follow new studies for MACULAR TELANGIECTASIA TYPE 2 (MACTEL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Eye implant for rare vision loss gets Long-Term safety check

Disease control Recruiting now

This study looks at the long-term safety of an eye implant called NT-501 for people with MacTel type 2, a rare disease that causes vision loss. About 285 adults who already received the implant in earlier studies, or who had a sham procedure, can join. The goal is to monitor side…

Matched conditions: MACULAR TELANGIECTASIA TYPE 2 (MACTEL)

Phase: PHASE4 • Sponsor: Neurotech Pharmaceuticals • Aim: Disease control

Last updated May 06, 2026 16:13 UTC

MACULAR TELANGIECTASIA TYPE 2 (MACTEL)

Get alerted when new MACULAR TELANGIECTASIA TYPE 2 (MACTEL) trials appear

Eye implant for rare vision loss gets Long-Term safety check